Bioarctic Ab Stock Performance
| BRCTF Stock | 33.14 2.15 6.09% |
On a scale of 0 to 100, BioArctic holds a performance score of 14. The firm shows a Beta (market volatility) of -0.74, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning BioArctic are expected to decrease at a much lower rate. During the bear market, BioArctic is likely to outperform the market. Please check BioArctic's variance, potential upside, as well as the relationship between the Potential Upside and day median price , to make a quick decision on whether BioArctic's price patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in BioArctic AB are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, BioArctic reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 999.9 M | |
| Total Cashflows From Investing Activities | -4.4 M |
BioArctic |
BioArctic Relative Risk vs. Return Landscape
If you would invest 2,782 in BioArctic AB on November 14, 2025 and sell it today you would earn a total of 532.00 from holding BioArctic AB or generate 19.12% return on investment over 90 days. BioArctic AB is currently producing 0.3008% returns and takes up 1.6785% volatility of returns over 90 trading days. Put another way, 15% of traded pink sheets are less volatile than BioArctic, and 94% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
BioArctic Target Price Odds to finish over Current Price
The tendency of BioArctic Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 33.14 | 90 days | 33.14 | about 55.2 |
Based on a normal probability distribution, the odds of BioArctic to move above the current price in 90 days from now is about 55.2 (This BioArctic AB probability density function shows the probability of BioArctic Pink Sheet to fall within a particular range of prices over 90 days) .
BioArctic Price Density |
| Price |
Predictive Modules for BioArctic
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as BioArctic AB. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of BioArctic's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
BioArctic Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. BioArctic is not an exception. The market had few large corrections towards the BioArctic's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold BioArctic AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of BioArctic within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.13 | |
β | Beta against Dow Jones | -0.74 | |
σ | Overall volatility | 2.22 | |
Ir | Information ratio | -0.01 |
BioArctic Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of BioArctic for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for BioArctic AB can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| BioArctic AB has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 23.15 M. Net Loss for the year was (119.79 M) with profit before overhead, payroll, taxes, and interest of 155.53 M. | |
| BioArctic generates negative cash flow from operations | |
| About 48.0% of the company shares are held by company insiders |
BioArctic Fundamentals Growth
BioArctic Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of BioArctic, and BioArctic fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BioArctic Pink Sheet performance.
| Return On Equity | -0.0142 | |||
| Return On Asset | -0.0055 | |||
| Profit Margin | (0.05) % | |||
| Current Valuation | 2.53 B | |||
| Shares Outstanding | 73.73 M | |||
| Price To Book | 28.65 X | |||
| Price To Sales | 104.82 X | |||
| Revenue | 23.15 M | |||
| EBITDA | (126.57 M) | |||
| Cash Flow From Operations | (140.46 M) | |||
| Earnings Per Share | 0.03 X | |||
| Total Asset | 897.73 M | |||
About BioArctic Performance
By analyzing BioArctic's fundamental ratios, stakeholders can gain valuable insights into BioArctic's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if BioArctic has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if BioArctic has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about BioArctic AB performance evaluation
Checking the ongoing alerts about BioArctic for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for BioArctic AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| BioArctic AB has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 23.15 M. Net Loss for the year was (119.79 M) with profit before overhead, payroll, taxes, and interest of 155.53 M. | |
| BioArctic generates negative cash flow from operations | |
| About 48.0% of the company shares are held by company insiders |
- Analyzing BioArctic's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BioArctic's stock is overvalued or undervalued compared to its peers.
- Examining BioArctic's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating BioArctic's management team can have a significant impact on its success or failure. Reviewing the track record and experience of BioArctic's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of BioArctic's pink sheet. These opinions can provide insight into BioArctic's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for BioArctic Pink Sheet analysis
When running BioArctic's price analysis, check to measure BioArctic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioArctic is operating at the current time. Most of BioArctic's value examination focuses on studying past and present price action to predict the probability of BioArctic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioArctic's price. Additionally, you may evaluate how the addition of BioArctic to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |